Drug Eluting Stents Market By Product Type (Polymer-Based Coatings (Non-Biodegradable Polymer-based, Biodegradable Polymer-Based), Polymer-Free Coatings (Micro Porous Surface, Micro Structured Surface, Slotted Tubular Surface, Nanoporous Surface); By Material Type (Cobalt Chromium (CoCr), Stainless Steel, Others); By Application (Coronary Artery Diseases, Peripheral Artery Diseases); By Region (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2018 – 2026
Industry Trends:
Drug Eluting Stents (DES) are implantable devices prominently used for the treatment of blocked arteries and blood vessels. It is an interventional method that delivers the drug by a controlled release through a biostable polymer. Components of drug eluting stents comprise a metallic stent platform, a drug delivery agent and polymer coating. Various drugs including Sirolimus, Everolimus, Paclitaxel, Dexamethasone, etc. are administered through these stents. DES products are explicitly developed to address the problem of restenosis, which is the recurrence of abnormal narrowing of an artery or valve after corrective surgery. Drug eluting stents are available in materials such as cobalt-chromium alloy, stainless steel and others. These cylindrically shaped devices are flexible, biocompatible, thromboresistant and are available in the form of laser-cut designs, coils, woven mesh designs, etc.
The number of patients suffering from diabetes and heart diseases has been increasingly consistently. Additionally, unhealthy diets and sedentary lifestyle habits are resulting in increased incidences of atherosclerosis, which is extensively being treated using drug eluting stents. However, their high cost of drug eluting stents in comparison to conventional stents is hampering the growth of Drug Eluting Stents Market. Some of the major risks associated with the use of traditional metallic implants include post-surgery complications such as neoatherosclerosis, impaired vessel homeostasis, and stent fracture. The ongoing technological advancements such as the use of bioresorbable materials as an alternative for the conventional metallic stents is eliminating several issues that arise after these surgeries. These modifications are extensively impacting a broad adoption of drug eluting stents based treatments.
Drug Eluting Stents Market is expected to grow with a CAGR of 7.5% during the forecast period of 2018 to 2026. The study analyzes the market in terms of revenue and sales volume across all the major markets.
Asia Pacific Drug Eluting Stents Sales (Thousand Units), 2017-2026
Competitive Landscape
The report provides both, qualitative and quantitative research of the drug eluting stents market, as well as provides worthy insights into the rational scenario and favored development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their headquarter, competitors, product/service type, application and specification, pricing, and gross margin.
The Drug Eluting Stents Market participants include QualiMed, B. Braun Melsungen AG, Arterius Limited (Arterius), Biosensors International Group, Ltd., Cook Medical Inc.(Cook), KYOTO MEDICAL PLANNING Co., Ltd., Elixir Medical Corporation, Biotronik SE & Co. KG, Abbott Laboratories (Abbott), Shanghai MicroPort Medical (MicroPort Scientific Corporation), TERUMO CORPORATION, Alvimedica, Boston Scientific Corporation, OrbusNeich Medical Company Limited (ORBUSNEICH), and Micell Technologies, Inc. amongst others. Abbott Vascular is a leading manufacturer of drug eluting stents, which is headquartered in California, U.S.A. Their everolimus-eluting platinum chromium coronary stent called Xience V is among the popular DES devices in this market. A similar Everolimus-Eluting Stent (EES) product by the name of PROMUS is launched by Boston Scientific, which is a company based in Marlborough, Massachusetts, US. The ongoing commercialization of drug eluting stents with polymer-free coatings and bioresorbable polymer coatings indicates a continuous growth of Drug Eluting Stents Market.
1. Introduction
1.1. Market Scope
1.2. Market Segmentation
1.3. Methodology
1.4. Assumptions
2. Drug Eluting Stents Market Snapshot
3. Executive Summary: Drug Eluting Stents Market
4. Qualitative Analysis: Drug Eluting Stents Market
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Development
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Trends in Drug Eluting Stents Market
5. Global Drug Eluting Stents Market Analysis and Forecasts,
2018 – 2026
5.1. Overview
5.1.1. Global Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts
5.2. Global Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
5.2.1. Polymer-Based Coatings (Definition, Market Penetration, Market
Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and
information on Non-Biodegradable Polymer-Based , Biodegradable Polymer-Based)
5.2.1.1. Non-Biodegradable Polymer-Based
5.2.1.2. Biodegradable Polymer-Based
5.2.2. Polymer-Free Coatings (Definition, Market Penetration, Market
Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and
information on Micro Porous Surface , Micro Structured Surface, Slotted Tubular
Surface , Nanoporous Surface)
5.2.2.1.
Micro Porous Surface
5.2.2.2.
Micro Structured Surface
5.2.2.3.
Slotted Tubular Surface
5.2.2.4.
Nanoporous Surface
5.3. Key Segment for Channeling Investments
5.3.1. By Product Type
6. Global Drug Eluting Stents Market Analysis and Forecasts,
2018 – 2026
6.1. Overview
6.2. Global Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
6.2.1. Cobalt Chromium (CoCr)
6.2.1.1. Definition
6.2.1.2. Market Penetration
6.2.1.3. Market Revenue Expected to Increase by 2026
6.2.1.4. Compound Annual Growth Rate (CAGR)
6.2.2. Stainless Steel
6.2.2.1.
Definition
6.2.2.2.
Market Penetration
6.2.2.3.
Market Revenue Expected
to Increase by 2026
6.2.2.4.
Compound Annual Growth
Rate (CAGR)
6.2.3. Others
6.2.3.1.
Definition
6.2.3.2.
Market Penetration
6.2.3.3.
Market Revenue Expected
to Increase by 2026
6.2.3.4.
Compound Annual Growth
Rate (CAGR)
6.3. Key Segment for Channeling Investments
6.3.1. By Material Type
7. Global Drug Eluting Stents Market Analysis and Forecasts,
2018 – 2026
7.1. Overview
7.2. Global Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
7.2.1. Coronary Artery Diseases
7.2.1.1.
Definition
7.2.1.2.
Market Penetration
7.2.1.3.
Market Revenue Expected
to Increase by 2026
7.2.1.4. Compound Annual Growth Rate (CAGR)
7.2.2. Peripheral Artery Diseases
7.2.2.1.
Definition
7.2.2.2.
Market Penetration
7.2.2.3.
Market Revenue Expected
to Increase by 2026
7.2.2.4. Compound Annual Growth Rate (CAGR)
7.3. Key Segment for Channeling Investments
7.3.1. By Application
8. North America Drug Eluting Stents Market Analysis and Forecasts,
2018 – 2026
8.1. Overview
8.1.1. North America Drug Eluting Stents Market Revenue (US$ Mn)
8.2. North America Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
8.2.1. Polymer-Based Coatings
8.2.1.1.
Non-Biodegradable
Polymer-Based
8.2.1.2.
Biodegradable Polymer-Based
8.2.2. Polymer-Free Coatings
8.2.2.1.
Micro Porous Surface
8.2.2.2.
Micro Structured Surface
8.2.2.3. Slotted Tubular Surface
8.2.2.4. Nanoporous Surface
8.3. North America Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
8.3.1. Cobalt Chromium (CoCr)
8.3.2. Stainless Steel
8.3.3. Others
8.4. North America Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
8.4.1. Coronary Artery Diseases
8.4.2. Peripheral Artery Diseases
8.5. North America Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Country
8.5.1. U.S.
8.5.1.1. U.S. Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
8.5.1.1.1. Polymer-Based Coatings
8.5.1.1.1.1.Non-Biodegradable
Polymer-Based
8.5.1.1.1.2.Biodegradable
Polymer-Based
8.5.1.1.2. Polymer-Free Coatings
8.5.1.1.2.1. Micro Porous Surface
8.5.1.1.2.2. Micro Structured Surface
8.5.1.1.2.3. Slotted Tubular Surface
8.5.1.1.2.4. Nanoporous Surface
8.5.1.2. U.S. Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
8.5.1.2.1.
Cobalt Chromium (CoCr)
8.5.1.2.2.
Stainless Steel
8.5.1.2.3.
Others
8.5.1.3. U.S. Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
8.5.1.3.1. Coronary Artery Diseases
8.5.1.3.2. Peripheral Artery Diseases
8.5.2. Rest of North America
8.5.2.1. Rest of North America Drug Eluting Stents Market Revenue (US$
Mn) and Forecasts, By Product Type
8.5.2.1.1. Polymer-Based Coatings
8.5.2.1.1.1. Non-Biodegradable Polymer-Based
8.5.2.1.1.2. Biodegradable Polymer-Based
8.5.2.1.2. Polymer-Free Coatings
8.5.2.1.2.1. Micro Porous Surface
8.5.2.1.2.2. Micro Structured Surface
8.5.2.1.2.3. Slotted Tubular Surface
8.5.2.1.2.4. Nanoporous Surface
8.5.2.2. Rest of North America Drug Eluting Stents Market Revenue (US$
Mn) and Forecasts, By Material Type
8.5.2.2.1. Cobalt Chromium (CoCr)
8.5.2.2.2. Stainless Steel
8.5.2.2.3. Others
8.5.2.3. Rest of North America Drug Eluting Stents Market Revenue (US$
Mn) and Forecasts, By Application
8.5.2.3.1. Coronary Artery Diseases
8.5.2.3.2.
Peripheral Artery Diseases
8.6. Key Segment for Channeling Investments
8.6.1. By Country
8.6.2. By Product Type
8.6.3. By Material Type
8.6.4. By Application
9. Europe Drug Eluting Stents Market Analysis and Forecasts,
2018 – 2026
9.1. Overview
9.1.1. Europe Drug Eluting Stents Market Revenue (US$ Mn)
9.2. Europe Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
9.2.1. Polymer-Based Coatings
9.2.1.1.
Non-Biodegradable
Polymer-Based
9.2.1.2. Biodegradable Polymer-Based
9.2.2. Polymer-Free Coatings
9.2.2.1. Micro Porous Surface
9.2.2.2. Micro Structured Surface
9.2.2.3. Slotted Tubular Surface
9.2.2.4. Nanoporous Surface
9.3. Europe Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
9.3.1. Cobalt Chromium (CoCr)
9.3.2. Stainless Steel
9.3.3. Others
9.4. Europe Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
9.4.1. Coronary Artery Diseases
9.4.2. Peripheral Artery Diseases
9.5. Europe Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Country
9.5.1. France
9.5.1.1. France Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
9.5.1.1.1. Polymer-Based Coatings
9.5.1.1.1.1. Non-Biodegradable Polymer-Based
9.5.1.1.1.2. Biodegradable Polymer-Based
9.5.1.1.2. Polymer-Free Coatings
9.5.1.1.2.1. Micro Porous Surface
9.5.1.1.2.2. Micro Structured Surface
9.5.1.1.2.3. Slotted Tubular Surface
9.5.1.1.2.4. Nanoporous Surface
9.5.1.2. France Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
9.5.1.2.1. Cobalt Chromium (CoCr)
9.5.1.2.2. Stainless Steel
9.5.1.2.3. Others
9.5.1.3. France Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
9.5.1.3.1. Coronary Artery Diseases
9.5.1.3.2. Peripheral Artery Diseases
9.5.2. The UK
9.5.2.1. The UK Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
9.5.2.1.1. Polymer-Based Coatings
9.5.2.1.1.1. Non-Biodegradable Polymer-Based
9.5.2.1.1.2. Biodegradable Polymer-Based
9.5.2.1.2. Polymer-Free Coatings
9.5.2.1.2.1. Micro Porous Surface
9.5.2.1.2.2. Micro Structured Surface
9.5.2.1.2.3. Slotted Tubular Surface
9.5.2.1.2.4. Nanoporous Surface
9.5.2.2. The UK Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
9.5.2.2.1. Cobalt Chromium (CoCr)
9.5.2.2.2. Stainless Steel
9.5.2.2.3. Others
9.5.2.3. The UK Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
9.5.2.3.1. Coronary Artery Diseases
9.5.2.3.2. Peripheral Artery Diseases
9.5.3. Spain
9.5.3.1. Spain Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
9.5.3.1.1. Polymer-Based Coatings
9.5.3.1.1.1. Non-Biodegradable Polymer-Based
9.5.3.1.1.2. Biodegradable Polymer-Based
9.5.3.1.2. Polymer-Free Coatings
9.5.3.1.2.1. Micro Porous Surface
9.5.3.1.2.2. Micro Structured Surface
9.5.3.1.2.3. Slotted Tubular Surface
9.5.3.1.2.4. Nanoporous Surface
9.5.3.2. Spain Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
9.5.3.2.1. Cobalt Chromium (CoCr)
9.5.3.2.2. Stainless Steel
9.5.3.2.3. Others
9.5.3.3. Spain Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
9.5.3.3.1. Coronary Artery Diseases
9.5.3.3.2. Peripheral Artery Diseases
9.5.4. Germany
9.5.4.1. Germany Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
9.5.4.1.1. Polymer-Based Coatings
9.5.4.1.1.1. Non-Biodegradable Polymer-Based
9.5.4.1.1.2. Biodegradable Polymer-Based
9.5.4.1.2. Polymer-Free Coatings
9.5.4.1.2.1. Micro Porous Surface
9.5.4.1.2.2. Micro Structured Surface
9.5.4.1.2.3. Slotted Tubular Surface
9.5.4.1.2.4. Nanoporous Surface
9.5.4.2. Germany Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
9.5.4.2.1. Cobalt Chromium (CoCr)
9.5.4.2.2. Stainless Steel
9.5.4.2.3. Others
9.5.4.3. Germany Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
9.5.4.3.1. Coronary Artery Diseases
9.5.4.3.2. Peripheral Artery Diseases
9.5.5. Italy
9.5.5.1. Italy Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
9.5.5.1.1. Polymer-Based Coatings
9.5.5.1.1.1. Non-Biodegradable Polymer-Based
9.5.5.1.1.2. Biodegradable Polymer-Based
9.5.5.1.2. Polymer-Free Coatings
9.5.5.1.2.1. Micro Porous Surface
9.5.5.1.2.2. Micro Structured Surface
9.5.5.1.2.3. Slotted Tubular Surface
9.5.5.1.2.4. Nanoporous Surface
9.5.5.2. Italy Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
9.5.5.2.1. Cobalt Chromium (CoCr)
9.5.5.2.2. Stainless Steel
9.5.5.2.3. Others
9.5.5.3. Italy Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
9.5.5.3.1.
Coronary Artery Diseases
9.5.5.3.2.
Peripheral Artery Diseases
9.5.6. Rest of Europe
9.5.6.1. Rest of Europe Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
9.5.6.1.1. Polymer-Based Coatings
9.5.6.1.1.1. Non-Biodegradable Polymer-Based
9.5.6.1.1.2. Biodegradable Polymer-Based
9.5.6.1.2. Polymer-Free Coatings
9.5.6.1.2.1. Micro Porous Surface
9.5.6.1.2.2. Micro Structured Surface
9.5.6.1.2.3. Slotted Tubular Surface
9.5.6.1.2.4. Nanoporous Surface
9.5.6.2. Rest of Europe Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
9.5.6.2.1. Cobalt Chromium (CoCr)
9.5.6.2.2. Stainless Steel
9.5.6.2.3. Others
9.5.6.3. Rest of Europe Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
9.5.6.3.1.
Coronary Artery Diseases
9.5.6.3.2.
Peripheral Artery Diseases
9.6. Key Segment for Channeling Investments
9.6.1. By Country
9.6.2. By Product Type
9.6.3. By Material Type
9.6.4. By Application
10. Asia Pacific Drug
Eluting Stents Market Analysis and Forecasts, 2018 – 2026
10.1. Overview
10.1.1. Asia Pacific Drug Eluting Stents Market Revenue (US$ Mn)
10.2. Asia Pacific Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
10.2.1. Polymer-Based Coatings
10.2.1.1. Non-Biodegradable Polymer-Based
10.2.1.2. Biodegradable Polymer-Based
10.2.2. Polymer-Free Coatings
10.2.2.1. Micro Porous Surface
10.2.2.2. Micro Structured Surface
10.2.2.3. Slotted Tubular Surface
10.2.2.4. Nanoporous Surface
10.3. Asia Pacific Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
10.3.1. Cobalt Chromium (CoCr)
10.3.2. Stainless Steel
10.3.3. Others
10.4. Asia Pacific Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
10.4.1. Coronary Artery Diseases
10.4.2. Peripheral Artery Diseases
10.5. Asia Pacific Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Country
10.5.1. China
10.5.1.1. China Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
10.5.1.1.1. Polymer-Based Coatings
10.5.1.1.1.1.
Non-Biodegradable
Polymer-Based
10.5.1.1.1.2.
Biodegradable Polymer-Based
10.5.1.1.2. Polymer-Free Coatings
10.5.1.1.2.1.
Micro Porous Surface
10.5.1.1.2.2.
Micro Structured Surface
10.5.1.1.2.3.
Slotted Tubular Surface
10.5.1.1.2.4. Nanoporous Surface
10.5.1.2. China Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
10.5.1.2.1. Cobalt Chromium (CoCr)
10.5.1.2.2. Stainless Steel
10.5.1.2.3. Others
10.5.1.3. China Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
10.5.1.3.1. Coronary Artery Diseases
10.5.1.3.2. Peripheral Artery Diseases
10.5.2. Japan
10.5.2.1. Japan Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
10.5.2.1.1. Polymer-Based Coatings
10.5.2.1.1.1.
Non-Biodegradable
Polymer-Based
10.5.2.1.1.2. Biodegradable Polymer-Based
10.5.2.1.2. Polymer-Free Coatings
10.5.2.1.2.1.
Micro Porous Surface
10.5.2.1.2.2.
Micro Structured Surface
10.5.2.1.2.3.
Slotted Tubular Surface
10.5.2.1.2.4.
Nanoporous Surface
10.5.2.2. Japan Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
10.5.2.2.1. Cobalt Chromium (CoCr)
10.5.2.2.2. Stainless Steel
10.5.2.2.3. Others
10.5.2.3. Japan Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
10.5.2.3.1. Coronary Artery Diseases
10.5.2.3.2. Peripheral Artery Diseases
10.5.3. India
10.5.3.1. India Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
10.5.3.1.1. Polymer-Based Coatings
10.5.3.1.1.1.
Non-Biodegradable
Polymer-Based
10.5.3.1.1.2. Biodegradable Polymer-Based
10.5.3.1.2. Polymer-Free Coatings
10.5.3.1.2.1.
Micro Porous Surface
10.5.3.1.2.2.
Micro Structured Surface
10.5.3.1.2.3.
Slotted Tubular Surface
10.5.3.1.2.4.
Nanoporous Surface
10.5.3.2. India Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
10.5.3.2.1. Cobalt Chromium (CoCr)
10.5.3.2.2. Stainless Steel
10.5.3.2.3. Others
10.5.3.3. India Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
10.5.3.3.1. Coronary Artery Diseases
10.5.3.3.2. Peripheral Artery Diseases
10.5.4. Southeast Asia
10.5.4.1. Southeast Asia Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
10.5.4.1.1. Polymer-Based Coatings
10.5.4.1.1.1.
Non-Biodegradable
Polymer-Based
10.5.4.1.1.2. Biodegradable Polymer-Based
10.5.4.1.2. Polymer-Free Coatings
10.5.4.1.2.1.
Micro Porous Surface
10.5.4.1.2.2.
Micro Structured Surface
10.5.4.1.2.3. Slotted Tubular Surface
10.5.4.1.2.4. Nanoporous Surface
10.5.4.2. Southeast Asia Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
10.5.4.2.1. Cobalt Chromium (CoCr)
10.5.4.2.2. Stainless Steel
10.5.4.2.3. Others
10.5.4.3. Southeast Asia Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
10.5.4.3.1. Coronary Artery Diseases
10.5.4.3.2. Peripheral Artery Diseases
10.5.5. Rest of Asia Pacific
10.5.5.1. Rest of Asia Pacific Drug Eluting Stents Market Revenue (US$
Mn) and Forecasts, By Product Type
10.5.5.1.1. Polymer-Based Coatings
10.5.5.1.1.1.
Non-Biodegradable
Polymer-Based
10.5.5.1.1.2. Biodegradable Polymer-Based
10.5.5.1.2. Polymer-Free Coatings
10.5.5.1.2.1.
Micro Porous Surface
10.5.5.1.2.2.
Micro Structured Surface
10.5.5.1.2.3.
Slotted Tubular Surface
10.5.5.1.2.4. Nanoporous Surface
10.5.5.2. Rest of Asia Pacific Drug Eluting Stents Market Revenue (US$
Mn) and Forecasts, By Material Type
10.5.5.2.1. Cobalt Chromium (CoCr)
10.5.5.2.2. Stainless Steel
10.5.5.2.3. Others
10.5.5.3. Rest of Asia Pacific Drug Eluting Stents Market Revenue (US$
Mn) and Forecasts, By Application
10.5.5.3.1. Coronary Artery Diseases
10.5.5.3.2. Peripheral Artery Diseases
10.6. Key Segment for Channeling Investments
10.6.1. By Country
10.6.2. By Product Type
10.6.3. By Material Type
10.6.4. By Application
11. Middle East and Africa Drug Eluting Stents Market Analysis and
Forecasts, 2018 – 2026
11.1. Overview
11.1.1. Middle East and Africa Drug Eluting Stents Market Revenue (US$
Mn)
11.2. Middle East and Africa Drug Eluting Stents Market Revenue (US$
Mn) and Forecasts, By Product Type
11.2.1. Polymer-Based Coatings
11.2.1.1. Non-Biodegradable Polymer-Based
11.2.1.2. Biodegradable Polymer-Based
11.2.2. Polymer-Free Coatings
11.2.2.1. Micro Porous Surface
11.2.2.2. Micro Structured Surface
11.2.2.3. Slotted Tubular Surface
11.2.2.4. Nanoporous Surface
11.3. Middle East and Africa Drug Eluting Stents Market Revenue (US$
Mn) and Forecasts, By Material Type
11.3.1. Cobalt Chromium (CoCr)
11.3.2. Stainless Steel
11.3.3. Others
11.4. Middle East and Africa Drug Eluting Stents Market Revenue (US$
Mn) and Forecasts, By Application
11.4.1. Coronary Artery Diseases
11.4.2. Peripheral Artery Diseases
11.5. Middle East and Africa Drug Eluting Stents Market Revenue (US$
Mn) and Forecasts, By Country
11.5.1. GCC Countries
11.5.1.1. GCC Countries Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
11.5.1.1.1. Polymer-Based Coatings
11.5.1.1.1.1.
Non-Biodegradable
Polymer-Based
11.5.1.1.1.2. Biodegradable Polymer-Based
11.5.1.1.2. Polymer-Free Coatings
11.5.1.1.2.1.
Micro Porous Surface
11.5.1.1.2.2.
Micro Structured Surface
11.5.1.1.2.3.
Slotted Tubular Surface
11.5.1.1.2.4.
Nanoporous Surface
11.5.1.2. GCC Countries Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
11.5.1.2.1. Cobalt Chromium (CoCr)
11.5.1.2.2. Stainless Steel
11.5.1.2.3. Others
11.5.1.3. GCC Countries Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
11.5.1.3.1. Coronary Artery Diseases
11.5.1.3.2. Peripheral Artery Diseases
11.5.2. Southern Africa
11.5.2.1. Southern Africa Drug Eluting Stents Market Revenue (US$ Mn)
and Forecasts, By Product Type
11.5.2.1.1. Polymer-Based Coatings
11.5.2.1.1.1.
Non-Biodegradable
Polymer-Based
11.5.2.1.1.2. Biodegradable Polymer-Based
11.5.2.1.2. Polymer-Free Coatings
11.5.2.1.2.1.
Micro Porous Surface
11.5.2.1.2.2.
Micro Structured Surface
11.5.2.1.2.3.
Slotted Tubular Surface
11.5.2.1.2.4.
Nanoporous Surface
11.5.2.2. Southern Africa Drug Eluting Stents Market Revenue (US$ Mn)
and Forecasts, By Material Type
11.5.2.2.1. Cobalt Chromium (CoCr)
11.5.2.2.2. Stainless Steel
11.5.2.2.3. Others
11.5.2.3. Southern Africa Drug Eluting Stents Market Revenue (US$ Mn)
and Forecasts, By Application
11.5.2.3.1. Coronary Artery Diseases
11.5.2.3.2. Peripheral Artery Diseases
11.5.3. Rest of MEA
11.5.3.1. Rest of MEA Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
11.5.3.1.1. Polymer-Based Coatings
11.5.3.1.1.1.
Non-Biodegradable
Polymer-Based
11.5.3.1.1.2. Biodegradable Polymer-Based
11.5.3.1.2. Polymer-Free Coatings
11.5.3.1.2.1.
Micro Porous Surface
11.5.3.1.2.2.
Micro Structured Surface
11.5.3.1.2.3.
Slotted Tubular Surface
11.5.3.1.2.4. Nanoporous Surface
11.5.3.2. Rest of MEA Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
11.5.3.2.1. Cobalt Chromium (CoCr)
11.5.3.2.2. Stainless Steel
11.5.3.2.3. Others
11.5.3.3. Rest of MEA Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
11.5.3.3.1. Coronary Artery Diseases
11.5.3.3.2. Peripheral Artery Diseases
11.6. Key Segment for Channeling Investments
11.6.1. By Country
11.6.2. By Product Type
11.6.3. By Material Type
11.6.4. By Application
12. Latin America Drug Eluting Stents Market Analysis and
Forecasts, 2018 – 2026
12.1. Overview
12.1.1. Latin America Drug Eluting Stents Market Revenue (US$ Mn)
12.2. Latin America Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
12.2.1. Polymer-Based Coatings
12.2.1.1. Non-Biodegradable Polymer-Based
12.2.1.2. Biodegradable Polymer-Based
12.2.2. Polymer-Free Coatings
12.2.2.1. Micro Porous Surface
12.2.2.2. Micro Structured Surface
12.2.2.3. Slotted Tubular Surface
12.2.2.4. Nanoporous Surface
12.3. Latin America Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
12.3.1. Cobalt Chromium (CoCr)
12.3.2. Stainless Steel
12.3.3. Others
12.4. Latin America Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
12.4.1. Coronary Artery Diseases
12.4.2. Peripheral Artery Diseases
12.5. Latin America Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Country
12.5.1. Brazil
12.5.1.1. Brazil Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Product Type
12.5.1.1.1. Polymer-Based Coatings
12.5.1.1.1.1.
Non-Biodegradable
Polymer-Based
12.5.1.1.1.2. Biodegradable Polymer-Based
12.5.1.1.2. Polymer-Free Coatings
12.5.1.1.2.1.
Micro Porous Surface
12.5.1.1.2.2.
Micro Structured Surface
12.5.1.1.2.3.
Slotted Tubular Surface
12.5.1.1.2.4. Nanoporous Surface
12.5.1.2. Brazil Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Material Type
12.5.1.2.1. Cobalt Chromium (CoCr)
12.5.1.2.2. Stainless Steel
12.5.1.2.3. Others
12.5.1.3. Brazil Drug Eluting Stents Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.1.3.1. Coronary Artery Diseases
12.5.1.3.2. Peripheral Artery Diseases
12.5.2. Rest of Latin America
12.5.2.1. Rest of Latin America Drug Eluting Stents Market Revenue (US$
Mn) and Forecasts, By Product Type
12.5.2.1.1. Polymer-Based Coatings
12.5.2.1.1.1.
Non-Biodegradable
Polymer-Based
12.5.2.1.1.2. Biodegradable Polymer-Based
12.5.2.1.2. Polymer-Free Coatings
12.5.2.1.2.1. Micro Porous Surface
12.5.2.1.2.2. Micro Structured Surface
12.5.2.1.2.3. Slotted Tubular Surface
12.5.2.1.2.4. Nanoporous Surface
12.5.2.2. Rest of Latin America Drug Eluting Stents Market Revenue (US$
Mn) and Forecasts, By Material Type
12.5.2.2.1. Cobalt Chromium (CoCr)
12.5.2.2.2. Stainless Steel
12.5.2.2.3. Others
12.5.2.3. Rest of Latin America Drug Eluting Stents Market Revenue (US$
Mn) and Forecasts, By Application
12.5.2.3.1. Coronary Artery Diseases
12.5.2.3.2. Peripheral Artery Diseases
12.6. Key Segment for Channeling Investments
12.6.1. By Country
12.6.2. By Product Type
12.6.3. By Material Type
12.6.4. By Application
13. Competitive Benchmarking
13.1. Player Positioning Analysis
13.2. Global Presence and Growth Strategies
14. Player Profiles
14.1. Abbott Laboratories (Abbott)
14.1.1. Company Details
14.1.2. Company Overview
14.1.3. Product Offerings
14.1.4. Key Developments
14.1.5. Financial Analysis
14.1.6. SWOT Analysis
14.1.7. Business Strategies
14.2. Alvimedica
14.2.1. Company Details
14.2.2. Company Overview
14.2.3. Product Offerings
14.2.4. Key Developments
14.2.5. Financial Analysis
14.2.6. SWOT Analysis
14.2.7. Business Strategies
14.3. Arterius Limited (Arterius)
14.3.1. Company Details
14.3.2. Company Overview
14.3.3. Product Offerings
14.3.4. Key Developments
14.3.5. Financial Analysis
14.3.6. SWOT Analysis
14.3.7. Business Strategies
14.4. B. Braun Melsungen AG
14.4.1. Company Details
14.4.2. Company Overview
14.4.3. Product Offerings
14.4.4. Key Developments
14.4.5. Financial Analysis
14.4.6. SWOT Analysis
14.4.7. Business Strategies
14.5. Biosensors International Group, Ltd.
14.5.1. Company Details
14.5.2. Company Overview
14.5.3. Product Offerings
14.5.4. Key Developments
14.5.5. Financial Analysis
14.5.6. SWOT Analysis
14.5.7. Business Strategies
14.6. Biotronik SE Co. KG
14.6.1. Company Details
14.6.2. Company Overview
14.6.3. Product Offerings
14.6.4. Key Developments
14.6.5. Financial Analysis
14.6.6. SWOT Analysis
14.6.7. Business Strategies
14.7. Boston Scientific Corporation
14.7.1. Company Details
14.7.2. Company Overview
14.7.3. Product Offerings
14.7.4. Key Developments
14.7.5. Financial Analysis
14.7.6. SWOT Analysis
14.7.7. Business Strategies
14.8. Cook Medical Inc.(Cook)
14.8.1. Company Details
14.8.2. Company Overview
14.8.3. Product Offerings
14.8.4. Key Developments
14.8.5. Financial Analysis
14.8.6. SWOT Analysis
14.8.7. Business Strategies
14.9. Elixir Medical Corporation
14.9.1. Company Details
14.9.2. Company Overview
14.9.3. Product Offerings
14.9.4. Key Developments
14.9.5. Financial Analysis
14.9.6. SWOT Analysis
14.9.7. Business Strategies
14.10. KYOTO MEDICAL PLANNING Co., Ltd.
14.10.1.
Company Details
14.10.2.
Company Overview
14.10.3.
Product Offerings
14.10.4.
Key Developments
14.10.5.
Financial Analysis
14.10.6.
SWOT Analysis
14.10.7.
Business Strategies
14.11. Micell Technologies, Inc.
14.11.1.
Company Details
14.11.2.
Company Overview
14.11.3.
Product Offerings
14.11.4.
Key Developments
14.11.5.
Financial Analysis
14.11.6.
SWOT Analysis
14.11.7.
Business Strategies
14.12. OrbusNeich Medical Company Limited (ORBUSNEICH)
14.12.1.
Company Details
14.12.2.
Company Overview
14.12.3.
Product Offerings
14.12.4.
Key Developments
14.12.5.
Financial Analysis
14.12.6.
SWOT Analysis
14.12.7.
Business Strategies
14.13. QualiMed
14.13.1.
Company Details
14.13.2.
Company Overview
14.13.3.
Product Offerings
14.13.4.
Key Developments
14.13.5.
Financial Analysis
14.13.6.
SWOT Analysis
14.13.7.
Business Strategies
14.14. Shanghai MicroPort Medical (MicroPort Scientific Corporation),
14.14.1.
Company Details
14.14.2.
Company Overview
14.14.3.
Product Offerings
14.14.4.
Key Developments
14.14.5.
Financial Analysis
14.14.6.
SWOT Analysis
14.14.7.
Business Strategies
14.15. TERUMO CORPORATION
14.15.1. Company Details
14.15.2. Company Overview
14.15.3. Product Offerings
14.15.4. Key Developments
14.15.5. Financial Analysis
14.15.6. SWOT Analysis
14.15.7. Business Strategies
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
